Additional Burden Averted in the United States From Use of MF59-Adjuvanted Seasonal Influenza Vaccine Compared With Standard Seasonal Influenza Vaccine Among Adults ≥65 Years

BACKGROUND: The MF59-adjuvanted trivalent inactivated influenza vaccine (aIIV3) is designed to overcome immunosenescence and enhance vaccine responses in older adults. We expanded on the Centers for Disease Control and Prevention (CDC) modeling method to estimate the number of additional influenza-r...

Descripción completa

Detalles Bibliográficos
Autores principales: McGovern, Ian, Sardesai, Aditya, Taylor, Alexandra, Toro-Diaz, Hector, Haag, Mendel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438869/
https://www.ncbi.nlm.nih.gov/pubmed/37601726
http://dx.doi.org/10.1093/ofid/ofad429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438869/
https://www.ncbi.nlm.nih.gov/pubmed/37601726
http://dx.doi.org/10.1093/ofid/ofad429

Ejemplares similares